A medical device for treating a heart valve may include a master staple and a loop fixed to the master staple prior to deployment of the master staple. The heart valve may be treated with that master staple and loop, and a plurality of follower staples that are independent from the loop prior to deployment of the master staple, by closing the master staple into the valve annulus, such that the point of the loop that is fixed to the master staple is fixed relative to the valve annulus, and engaging the loop with a plurality of follower staples after that closing.
|
1. A method performed on a heart having a valve with a valve annulus, comprising:
providing a master staple, a loop, and a plurality of follower staples;
connecting said loop to said master staple;
closing said master staple into the valve annulus only after said connecting, such that the point of said loop fixed to said master staple is fixed relative to the valve annulus; and
engaging the valve annulus and said loop with said plurality of follower staples only after said connecting and said closing said master staple;
wherein said follower staples are separate and independent from said loop prior to said closing of said master staple; and
wherein said connecting comprises tying one end of said loop to said master staple before said engaging and tying the other end of said loop to said master staple after said engaging.
3. The method of
4. The method of
5. The method of
|
The invention relates to an apparatus and method for performing heart valve surgery.
Annuloplasty is a procedure that treats or reconstructs a cardiac valve, usually the mitral valve. An annuloplasty ring is a device that is commonly used in that procedure. Referring to
The use of the same reference symbols in different figures indicates similar or identical items.
Referring to
The master staple 8 may be sized and shaped in any suitable manner. As one example, referring also to
The distal end of each tine 12 may have a substantially pointed or sharpened distal end. However, the distal ends of the tines 12 need not be pointed or sharpened, particularly if the cross-sectional area of each tine 12 is small. Advantageously, each tine 12 has a single distal end that is not bifurcated or otherwise forked or split. The body of the master staple 8 extends proximally from the distal end of one tine 12 and curves or angles toward the longitudinal centerline of the master staple 8. This curve may extend outward from the longitudinal centerline of the master staple 8, then toward the longitudinal centerline of the master staple 8. Alternately, the tine 12 may curve differently. The body of the master staple 8 reaches a peak 14, then extends distally and toward the longitudinal centerline of the master staple 8. The body of the master staple 8 then reaches a trough 16, then extends proximally and away from the longitudinal centerline of the staple to a second peak 14. The body of the master staple 8 continues distally to form the second tine 12, and ends at the distal end of the second tine 12. Alternately, the master staple 8 may be shaped differently. For example, the master staple 8 may have more than two tines 12. A valley 18 is the area on the master staple 8 on the other side of the master staple 8 from a peak 14. For example, where a peak 14 of the master staple 8 includes a convex curve oriented proximally, the corresponding valley 18 is a concave curve opening distally. Advantageously, the master staple 8 is substantially solid.
The master staple 8 may lie substantially in a single plane. That is, the master staple 8 is shaped such that a single plane extends through and substantially bisects the entire master staple 8. Alternately, the master staple 8 does not lie substantially in a single plane. The longitudinal and lateral dimensions of the master staple 8 overall may both be substantially larger than the height of the master staple 8. Alternately, the master staple 8 may be sized differently. The master staple 8 may be plastically deformable. If so, the master staple 8 may be fabricated from stainless steel, titanium or any other suitable plastically-deformable material. Alternately, the master staple 8 may be elastically deformable. If so, the master staple 8 may be fabricated from nickel-titanium alloy or any other suitable elastic or superelastic material. The master staple 8 may be fabricated from a single wire or other piece of material, having a rectangular, circular or other cross-section. The cross-section of the master staple 8 may be substantially constant along the entire master staple 8, or may vary at different locations along the master staple 8. For example, the cross-sectional area of the master staple 8 at certain locations may be less than at other locations, in order to promote bending in those locations having a lesser cross-sectional area.
The loop 10 may extend from any suitable part or parts of the master staple 8. As one example, referring back to
Referring to
An effector 26 holds the master staple 8 and a plurality of follower staples 20 prior to deployment. The master staple 8 is located distal to the follower staples 20, such that the master staple 8 is deployed first, as described in greater detail below. The effector 26 may be configured in any suitable manner. As one example, the effector 26 may be configured substantially as described in U.S. patent application Ser. No. 11/672,858, filed on Mar. 8, 2007, which is hereby incorporated by reference in its entirety. The loop 10 of the master staple 8 may be held completely within the effector 26 prior to deployment.
Operation
Referring to
With the effector 26 positioned in proximity to the valve annulus 4, the master staple 8 is ready for deployment. Advantageously, the master staple 8 is splayed, then closed. The master staple 8 may be moved longitudinally after it has been splayed and before it is closed. However, the master staple 8 need not be splayed prior to closure. Examples of such splaying, closing and longitudinal motion are provided in U.S. Pat. No. 7,344,544 and in U.S. patent application Ser. No. 11/672,858, filed on Mar. 8, 2007, both of which are hereby incorporated by reference in their entirely. Motion of the distal ends of the tines 12 of the master staple 8 apart from one another, each in a direction away from the longitudinal centerline of the master staple 8, is referred to as “splaying.” Splaying may be performed by holding the valleys 18 in a substantially fixed position, and applying a distal force to the trough 16 of the master staple 8 at a location closer to the longitudinal centerline of the master staple 8 than the location at which the valleys 18 are held. Alternately, splaying may be performed in any other suitable manner.
Next, the master staple 8 is advanced relative to the valve annulus 4 such that the tines 12 penetrate into the tissue of the valve annulus 4. The effector 26 may be held substantially stationary relative to the valve annulus 4, and the master staple 8 may be advanced along the effector 26 into tissue. As another example, the effector 26 as a whole may be moved closer to the valve annulus 4 after splaying the master staple 8, until the tines 12 penetrate the tissue of the valve annulus 4; if so, the master staple 8 need not be movable relative to the effector 26 between splaying and closing.
Next, the effector 26 is actuated to close the master staple 8, attaching the master staple 8 to the valve annulus 4, as shown in
Next, the follower staples 20 held by the effector 26 are sequentially deployed. Because the follower staples 20 are individually deployed, the surgeon has the option to place the follower staples 20 in any order or location on the valve annulus 4, to ensure successful placement and distribution of the loop 10 and thereby ensure successful treatment. The follower staples 20 may be shaped substantially the same as the master staple 8, and may be splayed and closed in substantially the same way. Alternately, the follower staples 20 are splayed and closed in a different way. The follower staples 20 may advance distally relative to the effector 26 after splaying and before closing, or may be substantially stationary relative to the effector 26 after splaying and before closing. Alternately, at least one of the follower staples 20 need not be splayed before closing. The engagement feature 22 of each follower staple 20 is moved into engagement with the loop 10 of the master staple 8 before closure of that follower staple 20. The engagement feature 22 of a follower staple 20 may engage the loop 10 before or after splaying of that follower staple 20. The engagement feature 22 may engage the loop 10 in any suitable manner. As one example, where the engagement feature 22 includes a notch 24, the engagement feature 22 is moved toward the loop 10 until the notch 24 receives the loop 10. The loop 10 may have a thickness slightly greater than the width of the notch 24, such that the loop 10 is compressed by its entry into the notch 24, and thereby is held securely by the notch 24 after its capture. However, the engagement feature 22 may engage the notch 24 in any suitable manner. Engagement between the engagement feature 22 of the follower staple 20 and the loop 10 may be visualized by fluoroscopy or by any other suitable method. Alternately, at least one follower staple 20 engages the loop 10 during its closure, where the loop 10 is trapped between the follower staple 20 and the tissue of the valve annulus 4, and the tines 12 of the follower staple 20 close around the loop 10. If so, the engagement feature 22 may be omitted from the follower staple 20.
Referring also to
While the invention has been described in detail, it will be apparent to one skilled in the art that various changes and modifications can be made and equivalents employed, without departing from the present invention. It is to be understood that the invention is not limited to the details of construction, the arrangements of components, and/or the method set forth in the above description or illustrated in the drawings. Further, the invention is not limited to the performance of heart valve surgery. Statements in the abstract of this document, and any summary statements in this document, are merely exemplary; they are not, and cannot be interpreted as, limiting the scope of the claims. Further, the figures are merely exemplary and not limiting. Topical headings and subheadings are for the convenience of the reader only. They should not and cannot be construed to have any substantive significance, meaning or interpretation, and should not and cannot be deemed to indicate that all of the information relating to any particular topic is to be found under or limited to any particular heading or subheading. Therefore, the invention is not to be restricted or limited except in accordance with the following claims and their legal equivalents.
Clauson, Luke W., Knodel, Bryan D., Hausen, Bernard A.
Patent | Priority | Assignee | Title |
10076414, | Feb 13 2012 | Method and apparatus for repairing a mitral valve | |
11414733, | Dec 26 2017 | JFE Steel Corporation | Low-alloy high-strength seamless steel pipe for oil country tubular goods |
11453924, | Dec 26 2017 | JFE Steel Corporation | Low-alloy high-strength seamless steel pipe for oil country tubular goods |
11505842, | Dec 26 2017 | JFE Steel Corporation | Low-alloy high-strength seamless steel pipe for oil country tubular goods |
8734484, | Apr 21 2009 | Medtronic, Inc | System and method for closure of an internal opening in tissue, such as a trans-apical access opening |
9011531, | Feb 13 2012 | MITRASPAN, INC | Method and apparatus for repairing a mitral valve |
9155536, | Apr 26 2011 | Aesculap AG | Circular stapler |
9445899, | Aug 22 2012 | Method and apparatus for mitral valve annuloplasty |
Patent | Priority | Assignee | Title |
4586503, | Dec 01 1983 | University of New Mexico | Surgical microclip |
4932965, | Dec 19 1988 | Artificial valve, and needle and suture holder and method of using same | |
5242457, | May 08 1992 | Ethicon, Inc. | Surgical instrument and staples for applying purse string sutures |
5607442, | Nov 13 1995 | Cordis Corporation | Stent with improved radiopacity and appearance characteristics |
5891160, | Feb 21 1997 | CardioVascular Technologies, LLC | Fastener delivery and deployment mechanism and method for placing the fastener in minimally invasive surgery |
6001127, | Mar 31 1998 | ST JUDE MEDICAL, INC | Annuloplasty ring holder |
6254615, | Feb 24 1995 | Heartport, Inc. | Surgical clips and methods for tissue approximation |
6409758, | Jul 27 2000 | Edwards Lifesciences Corporation | Heart valve holder for constricting the valve commissures and methods of use |
6413274, | Jan 27 1998 | United States Surgical Corporation | Stapling apparatus and method for heart valve replacement |
6506197, | Nov 15 2000 | Ethicon, Inc | Surgical method for affixing a valve to a heart using a looped suture combination |
6695866, | Jul 15 1998 | St. Jude Medical, Inc. | Mitral and tricuspid valve repair |
6726716, | Aug 24 2001 | Edwards Lifesciences Corporation | Self-molding annuloplasty ring |
6730118, | Oct 11 2001 | EDWARDS LIFESCIENCES PVT, INC | Implantable prosthetic valve |
6986775, | Jun 13 2002 | ANCORA HEART, INC | Devices and methods for heart valve repair |
7285131, | Jul 28 1999 | Aesculap AG | System for performing anastomosis |
7344544, | Mar 28 2005 | Aesculap AG | Vascular closure system |
7473258, | Mar 08 2007 | Aesculap AG | Surgical stapler |
7485142, | Dec 21 2001 | QUICKRING MEDICAL TECHNOLOGIES LTD | Implantation system for annuloplasty rings |
7513909, | Apr 08 2005 | Medtronic, Inc | Two-piece prosthetic valves with snap-in connection and methods for use |
7753922, | Sep 04 2003 | ANCORA HEART, INC | Devices and methods for cardiac annulus stabilization and treatment |
7918873, | Jun 07 2001 | Abbott Vascular Inc | Surgical staple |
7922762, | Sep 04 2003 | ANCORA HEART, INC | Devices and methods for cardiac annulus stabilization and treatment |
20030195514, | |||
20040138705, | |||
20040167620, | |||
20040236419, | |||
20040243230, | |||
20040262461, | |||
20040267310, | |||
20050065601, | |||
20050216079, | |||
20050251252, | |||
20050267572, | |||
20060015144, | |||
20060025784, | |||
20060106456, | |||
20060253143, | |||
20060282118, | |||
20070010854, | |||
20070129794, | |||
20070208360, | |||
20070219570, | |||
20080051807, | |||
20080058868, | |||
20080296344, | |||
20090039138, | |||
20090318957, | |||
20110178466, | |||
D574956, | Jun 28 2007 | BioMedical Enterprises, Inc | Soft tissue staple |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jun 02 2008 | HAUSEN, BERNARD A | Cardica, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 021042 | /0981 | |
Jun 02 2008 | CLAUSON, LUKE W | Cardica, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 021042 | /0981 | |
Jun 03 2008 | Cardica, Inc. | (assignment on the face of the patent) | / | |||
Jun 03 2008 | KNODEL, BRYAN D | Cardica, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 021042 | /0981 | |
Feb 14 2018 | DEXTERA SURGICAL INC | AESDEX, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 045870 | /0478 | |
Feb 20 2018 | AESDEX, LLC | Aesculap AG | ASSET PURCHASE AGREEMENT | 045870 | /0567 |
Date | Maintenance Fee Events |
Dec 04 2015 | REM: Maintenance Fee Reminder Mailed. |
Apr 24 2016 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Apr 24 2015 | 4 years fee payment window open |
Oct 24 2015 | 6 months grace period start (w surcharge) |
Apr 24 2016 | patent expiry (for year 4) |
Apr 24 2018 | 2 years to revive unintentionally abandoned end. (for year 4) |
Apr 24 2019 | 8 years fee payment window open |
Oct 24 2019 | 6 months grace period start (w surcharge) |
Apr 24 2020 | patent expiry (for year 8) |
Apr 24 2022 | 2 years to revive unintentionally abandoned end. (for year 8) |
Apr 24 2023 | 12 years fee payment window open |
Oct 24 2023 | 6 months grace period start (w surcharge) |
Apr 24 2024 | patent expiry (for year 12) |
Apr 24 2026 | 2 years to revive unintentionally abandoned end. (for year 12) |